According to the enterprise research app, recently, Chengdu Vanoxi Biomedical Technology Co., Ltd. underwent business changes, adding Haizheng Pharmaceutical and others as shareholders. Earlier, Haizheng Pharmaceutical announced that it plans to invest 30 million yuan in Vanoxi to participate in the current round of capital increases. After the investment is completed, the company will hold 8.57% of Vanoxi's shares.
海正药业投资创新药物研究企业凡诺西
Haizheng Pharmaceutical invests in innovative drug research enterprise Vanosi
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.